Evidence map›Paper›PMID 40894178›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Neurocognition After Perturbed Sleep (NAPS): A Protocol for an Experimental Study Examining the Impact of Sleep on Neurocognition, Functioning, and Clinical Indicators in People with Schizophrenia.

S A Miller, L H Ospina, A E Mullins, A Parekh, K Kam, C R Fowler, A W Varga, D Kimhy

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

S A MillerDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0002-7336-9891
L H OspinaDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0002-5808-0897
A E MullinsMount Sinai Integrative Sleep Center, Division of Pulmonary, Critical Care, and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0002-5143-6977
A ParekhMount Sinai Integrative Sleep Center, Division of Pulmonary, Critical Care, and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0002-5396-0553
K KamMount Sinai Integrative Sleep Center, Division of Pulmonary, Critical Care, and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0001-7011-9080
C R FowlerDepartment of Mathematical Sciences, Worcester Polytechnic Institute, Worcester, MA, USA.ORCID 0000-0002-5403-6346
A W VargaMount Sinai Integrative Sleep Center, Division of Pulmonary, Critical Care, and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0002-3668-3371
D KimhyDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0001-7735-9378

Funding

Neurocognition After Perturbed Sleep (NAPS)R21MH126357 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KIMHY, DAVID · 2021 to 2022
$464k
NIMH NIH HHS R21 MH126357
6 · The paper itself

Abstract

Introduction: People with schizophrenia (SZ) display neurocognitive deficits that have been identified as predictors of poor functioning and disability. Previous reports have noted that these deficits are strikingly similar to the cognitive sequalae of poor sleep. Consistent with this observation, extensive animal and basic human research have strongly support the deleterious effects of poor sleep on neurocognition. Notably, insomnia and disturbed sleep (DS) are highly ubiquitous among people with SZ. Yet, there is scarce information about the potential impact of poor sleep on neurocognition in this population, with available studies using correlational or cross-sectional designs. Method: We will employ an experimental, within-person, cross-over design to characterize sleep architecture, duration, continuity and quality along with their neurocognitive, functional, electrophysiological, and clinical sequalae in individuals with SZ. Participants will complete two overnight lab-based polysomnography examinations (two weeks apart) employing two sleep schedules: 1) undisturbed sleep (8 hours); and 2) perturbed sleep (4 hours). As part of each overnight sleep schedule, participants will complete brief EEG-indexed sleep-sensitive memory tasks pre- and post-sleep, a post-sleep neurocognitive test battery, as well as a three-day post-sleep digital phenotyping of physical activity, daily functioning, mood, symptoms, medication side-effects, and suicidal ideation via smartphones and actigraphy. Discussion: Despite their chronic and ubiquitous nature, the impact of insomnia and DS on neurocognition in SZ remain poorly understood and modeled. This lack of information hinders our ability to develop accurate treatment models and effective interventions for neurocognitive deficits in SZ. Our aim is to address these gaps in knowledge.

Identifiers

PMID40894178
PMCPMC12393638

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.